Anna Sjögren
Director Técnico/Científico/I+D en EGETIS THERAPEUTICS AB .
Origen de la red de primer grado Anna Sjögren.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.
6
| Holding Company | Pharmaceuticals: Generic | 6 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Anna Sjögren a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| University of Uppsala | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director of Finance/CFO Director/Board Member General Counsel | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Stockholm School of Economics | College/University | Masters Business Admin Masters Business Admin | |
Rare Thyroid Therapeutics International AB
 Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Biotechnology | Founder Chief Executive Officer | |
Flamingo Therapeutics BV
 Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Chairman Director/Board Member | |
| University of Gothenburg | College/University | Doctorate Degree Doctorate Degree | |
Immedica Pharma AB
 Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Founder | |
| University of Lund | College/University | Undergraduate Degree Graduate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Public Communications Contact Investor Relations Contact | |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Karolinska Institutet | College/University | Doctorate Degree | |
Avidicare AB
 Avidicare AB Medical DistributorsDistribution Services Avidicare AB operates as a medical device company. It specializes in the management of airborne bacteria and virus pollution at hospitals. The firm provides Opragon, a ventilation system for reduction of airborne bacterial contamination in various hospital environments primarily for infection sensitive surgery. The company offers Opragon for preparation rooms, operating theaters, and hybrid rooms; and air curtains and external air showers. Avidicare was founded in 2010 and is headquartered in Lund, Sweden. | Medical Distributors | Director/Board Member | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Comptroller/Controller/Auditor | |
Pareto Securities AB
 Pareto Securities AB Investment Banks/BrokersFinance Pareto Securities AB is the Swedish brokerage subsidiary of Pareto Securities AS, itself a subsidiary of Pareto AS in Norway. Headquartered in Stockholm, the firm provides full spectrum of brokerage services specifically tailored for both retail and institutional investors. They has expertise in Nordic capital markets and a strong international presence within the oil, offshore, shipping and natural resources sectors. | Investment Banks/Brokers | Analyst-Equity | |
| Cetoros AB | Chief Executive Officer | ||
| REDX PHARMA PLC | Pharmaceuticals: Major | Investor Relations Contact | |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Biotechnology | Chief Executive Officer | |
| University of Utrecht | College/University | Doctorate Degree | |
| FLERIE INVEST AB | Pharmaceuticals: Major | Director/Board Member | |
| TTM HoldCo AB | Chief Executive Officer | ||
| Immedica Pharma Holding AB | Director/Board Member | ||
| University of Leiden | College/University | Corporate Officer/Principal | |
| University of Helsinki | College/University | Graduate Degree | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Instituto de Estudios Superiores de la Empresa | College/University | Masters Business Admin | |
| ANOTO GROUP AB | Computer Peripherals | Director of Research - Fxd Inc | |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Medical Specialties | Director/Board Member | |
| ALTAMIRA THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | Biotechnology | Director of Finance/CFO | |
| ACTIVE BIOTECH AB | Biotechnology | Director of Finance/CFO | |
| Pephexia Therapeutics ApS | Director/Board Member | ||
| Venaticus Capital AB | Director/Board Member | ||
| Swedish Armed Forces Language Institute | College/University | Undergraduate Degree | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Founder | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal |
Estadísticas
Internacional
| Suecia | 29 |
| Países Bajos | 7 |
| Dinamarca | 4 |
| Suiza | 4 |
| Reino Unido | 3 |
Sectorial
| Health Technology | 25 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 4 |
| Health Services | 2 |
Operativa
| Director/Board Member | 96 |
| Corporate Officer/Principal | 39 |
| Chairman | 32 |
| Independent Dir/Board Member | 25 |
| Chief Executive Officer | 18 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Georges Gemayel | 33 |
| Khalid Islam | 29 |
| Rémi Droller | 29 |
| Matthew Gantz | 16 |
| Lena Elisabeth Svanberg | 16 |
| Mats Blom | 15 |
| Peder Sven Walberg | 15 |
| Yilmaz Mahshid | 12 |
| Thomas Lönngren | 11 |
| Gunilla Christina Osswald | 9 |
| Malin Nittve | 8 |
| Nicklas Westerholm | 7 |
| Karl Hård | 7 |
| Henrik Krook | 5 |
| Bastian Dehmel | 4 |
- Bolsa de valores
- Insiders
- Anna Sjögren
- Conexiones Empresas
